Retinopathy of prematurity: Aetiology

Clinical Risk

Volumn 3, Issue 2, 1997, Pages 47-51

  Fielder, Alistair R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992845466     PISSN: 13562622     EISSN: 17581028     Source Type: Journal    
DOI: 10.1177/135626229700300204     Document Type: Article

References (23)

1. Patz A, Hoeck LE, de la Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. Am J Ophthalmol 1952; 35: 1248–1252
2. Crosse VM, Evans PJ. Prevention of retrolental fibroplasia. Arch Ophthalmol 1952; 48: 83–87
3. Gordon HH, Lubchenco L, Hix I. Observations on the etiology of retrolental fibroplasia. Bull J Hopkins Hosp 1954; 94: 34–44
4. Lanman JT, Guy LP, Dancis J. Retrolental fibroplasia and oxygen therapy. JAMA 1954; 155: 223–226
5. Kinsey VE. Retrolental Fibroplasia. Cooperative Study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol 1956; 56: 481–543
6. Ashton N. Oxygen and retinal blood vessels. Trans Ophthalmol Soc UK 1980; 100: 359–362
7. Patz A. Retrolental fibroplasia (retinopathy of prematurity). Trans Ophthalmol Soc NZ 1980; 32: 49–54
8. Committee on Fetus and Newborn. Oxygen therapy in the newborn infant. Pediatrics 1971; 47: 1086–1087
9. Lucey JF, Dangman B. A re-examination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984; 73: 82–96
10. Flynn JT, Bancalari E, Snyder ES, et al. A cohort study of transcutaneous oxygen monitoring and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050–1054
11. Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fujimua M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefe's Arch Clin Exp Ophthalmol 1993; 231: 151–156
12. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995; 346: 1464–1465
13. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995; 1: 1024–1028
14. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996; 37: 290–299
15. Kretzer FL, Hittner HM. Retinopathy of prematurity: Clinical implications of retinal development. Arch Dis Child 1988; 63: 1151–1167
16. Prendiville A, Schulenburg WE. Clinical factors associated with retinopathy of prematurity. Arch Dis Child 1988; 63: 522–527
17. Weakley DR, Spencer R. Current concepts in retinopathy of prematurity. Early Hum Dev 1992; 30: 121–138
18. Gallo JE, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr 1993; 82: 829–834
19. Fielder AR. Retinopathy of prematurity. Curr Paediatr 1996; 6: 56–61
20. Hungerford J, Stewart A, Hope P. Ocular sequelae of preterm birth and their relation to ultrasound evidence of cerebral damage. Br J Ophthalmol 1986; 70: 463–468
21. Ng YK, Fielder AR, Levene MI, Trounce JQ, McLellan N. Are severe retinopathy of prematurity and severe periventricular leukomalacia both ischaemic insults? Br J Ophthalmol 1989; 73: 111–114
22. Chan-Ling T, Gock B, Stone J. Supplemental oxygen therapy: Basis for noninvasive treatment of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1995; 35: 1215–1230
23. Jandeck C, Kellner U, Kossel H, Bartsch M, Versmold HT, Foerster M.H., Retinopathy of prematurity in infants of birth weight >2000 g after haemorrhagic shock at birth. Br J Ophthalmol 1996; 80: 728–731